HUM

Humana Inc.
$389.32
-5.18 (-1.31%)
Mkt Cap 46.74B
Volume 740,260
52W Range 163.11-428.88
Sector Healthcare
Beta 0.72
EPS (TTM) 9.38
P/E Ratio 41.51
Revenue (TTM) 137.20B
Rev Growth (5Y) +10.9%
EPS Growth (5Y) -17.3%
AlphaVal · Fair Value
What we estimate one share is worth
$277.92
Overvalued strong signal
40.1% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C+
Stable Earnings Power
60.9 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 129.66B 117.81B 106.44B 92.92B 83.65B 77.19B 64.93B 56.94B 53.80B 54.41B 54.29B 48.50B
Net Income 1.19B 1.21B 2.49B 2.81B 2.93B 3.37B 2.71B 1.68B 2.45B 614.00M 1.28B 1.15B
EPS 9.87 10.01 20.09 22.20 22.79 25.47 20.19 12.24 16.94 4.11 8.54 7.44
Free Cash Flow 375.00M 2.39B 2.98B 3.45B 920.00M 4.67B 4.55B 1.56B 3.52B 1.41B 345.00M 1.09B
FCF / Share 3.11 19.83 24.03 27.29 7.15 35.36 33.93 11.35 24.40 9.43 2.31 7.07
Operating CF 921.00M 2.97B 3.98B 4.59B 2.26B 5.64B 5.28B 2.17B 4.05B 1.94B 868.00M 1.62B
Total Assets 48.75B 46.31B 46.89B 43.73B 44.75B 35.08B 29.04B 25.34B 26.68B 25.81B 25.12B 23.45B
Total Debt 12.94B 12.26B 12.27B 11.75B 13.22B 7.14B 6.11B 6.07B 4.92B 4.09B 4.09B 3.83B
Cash & Equiv 4.20B 2.22B 4.69B 5.06B 3.39B 4.67B 4.05B 2.34B 4.04B 3.88B 2.57B 1.94B
Book Value 17.66B 16.38B 16.26B 15.31B 16.08B 13.73B 12.04B 10.16B 9.84B 10.69B 10.35B 9.65B
Return on Equity 0.07 0.07 0.15 0.18 0.18 0.25 0.22 0.17 0.25 0.06 0.12 0.12
HUM News
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
Jul 24, 2026 09:41 AM · zacks.com
IMAX price target boosted by Wedbush on growth outlook
Jul 24, 2026 03:31 AM · proactiveinvestors.com
Wise tumbles as US regulator rejects banking licence application
Jul 24, 2026 01:14 AM · proactiveinvestors.com
Freeport-McMoRan shares slip despite second quarter earnings beat as copper outlook softens
Jul 23, 2026 05:07 AM · proactiveinvestors.com
Custom Health wins Buy rating from Stifel, then seals a pharmacy deal to match
Jul 23, 2026 04:28 AM · proactiveinvestors.com
Kaskela Law Firm Announces Investigation of Humana Inc. (HUM) and Encourages Long-Term HUM Shareholders to Contact the Firm
Jul 23, 2026 03:00 AM · businesswire.com
Nomura Core Equity Fund Q2 2026 Portfolio Review
Jul 22, 2026 08:35 AM · seekingalpha.com
Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?
Jul 22, 2026 07:01 AM · zacks.com
Humana Inc. $HUM Shares Sold by California Public Employees Retirement System
Jul 21, 2026 11:45 PM · defenseworld.net
Humana (HUM) is a Great Momentum Stock: Should You Buy?
Jul 21, 2026 09:01 AM · zacks.com